[Ip-health] Indian generic ledipasvir and sofosbuvir co-formulation availability and pricing update.

Giten Khwairakpam giten.khwairakpam at treatasia.org
Mon May 2 19:31:55 PDT 2016


Dear friends and colleagues, Please find the updated availability and pricing of Indian generic ledipasvir and sofosbuvir co-formulated tablets as on 26th April 2016.

http://hepcasia.com/2016/05/03/pricing-and-availability-of-generic-indian-ledipasvir-and-sofosbuvir-co-formulation-as-on-26-april-2016/

As you will note, the prices has been decreasing rapidly and there will soon be new companies who will market their own brands soon, which we hope to provide you with in the next update. Though these are prices at individual patient purchases, lot of people still find it hard to afford these medicines, at least in our Asian context. There are other major barriers, like treatment education, diagnostics, building skills among non-specialist and national drug regulatory processes which we all have to address to improve access.

Please do not hesitate to let me know if you have any questions.

Thanks
Giten

Giten. Khwairakpam
Project Manager, Community and Policy

TREAT Asia/amfAR – The Foundation for AIDS Research
388 Sukhumvit Road, Suite 2104
Klongtoey, Bangkok 10110
Thailand
t. +66 2 663 7561
f. +66 2 663 7562
www.treatasia.org<http://www.treatasia.org/>


More information about the Ip-health mailing list